Researchers at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) have uncovered previously unobserved oscillation ...

Shift4 (FOUR) stock analysis: slowing revenue but improving margins, 20% short interest and big buyback raise short-squeeze ...

The Central Board of Secondary Education (CBSE) will conduct the Class 12 Physics exam on February 20, 2026. For many ...

As the backlash grew, Singh clarified that his remarks had been misconstrued. (PTI) Senior Congress leader and Rajya Sabha MP Digvijaya Singh on Saturday found himself at the centre of a controversy ...

RBSE 12th Time Table 2026: The Rajasthan Board of Secondary Education (RBSE), Ajmer has officially released the RBSE Class 12 Date Sheet 2026 for students appearing in the RBSE 12th Board Examinations ...

Forbes contributors publish independent expert analyses and insights. Tim Newcomb covers tennis gear/business, stadiums and shoe tech. Mizuno’s flagship tennis footwear gets a complete update this ...

Hyderabad woke up to unusually cold weather on Thursday, with temperatures slipping to 7°C within Greater Hyderabad Municipal Corporation (GHMC) limits. (Photo: X/@Hyderabadrains) The cold wave ...

King James is known for having one of the longest sneaker lines in Nike history, and it only seems to get better with time. I’ve said before that ever since the LeBron 20s, his sneakers have been some ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

D-Wave Quantum’s stock has gone on a wild ride since its public debut. It’s locking in a lot of customers but barely generating any revenue from them. Its sky-high valuations could limit its near-term ...

It wasn't hard to be optimistic about the biotech's future, given its excellent news from the lab on Monday. Prognosticators fell over themselves publishing bullish new takes on the company the ...

Wave Life Sciences Ltd. (NASDAQ: WVE) on Monday shared interim data from the lowest therapeutic cohort of the ongoing first-in-human INLIGHT trial evaluating WVE-007, an investigational INHBE ...